Check-Cap Ltd.

AI Score

0

Unlock

1.28
-0.22 (-14.67%)
At close: Jan 14, 2025, 3:59 PM
1.22
-5.06%
Pre-market Jan 15, 2025, 06:25 AM EST
undefined%
Bid 1.2
Market Cap 7.52M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -2.14
PE Ratio (ttm) -0.6
Forward PE n/a
Analyst Hold
Ask 1.28
Volume 133,404
Avg. Volume (20D) 1,293,793
Open 1.37
Previous Close 1.50
Day's Range 1.27 - 1.42
52-Week Range 0.56 - 3.45
Beta undefined

About CHEK

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through ...

Sector Healthcare
IPO Date Mar 4, 2015
Employees 85
Stock Exchange NASDAQ
Ticker Symbol CHEK

Analyst Forecast

According to 1 analyst ratings, the average rating for CHEK stock is "Hold." The 12-month stock price forecast is $undefined, which is a decrease of NaN% from the latest price.

Buy 0.00%
Hold 100.00%
Sell 0.00%
Stock Forecasts
1 week ago · Source
+17.18%
Check-Cap shares are trading higher after the comp... Unlock content with Pro Subscription
9 months ago · Source
+25.38%
Check-Cap shares are trading higher after the company announced that it entered into a definitive Business Combination Agreement with Nobul AI.